STX.L
Shield Therapeutics PLC
Price:  
2.83 
GBP
Volume:  
2,691,651.00
United Kingdom | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

STX.L WACC - Weighted Average Cost of Capital

The WACC of Shield Therapeutics PLC (STX.L) is 29.0%.

The Cost of Equity of Shield Therapeutics PLC (STX.L) is 9.75%.
The Cost of Debt of Shield Therapeutics PLC (STX.L) is 51.75%.

Range Selected
Cost of equity 8.30% - 11.20% 9.75%
Tax rate 2.20% - 2.90% 2.55%
Cost of debt 7.00% - 96.50% 51.75%
WACC 7.6% - 50.5% 29.0%
WACC

STX.L WACC calculation

Category Low High
Long-term bond rate 4.0% 4.5%
Equity market risk premium 6.0% 7.0%
Adjusted beta 0.72 0.88
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.30% 11.20%
Tax rate 2.20% 2.90%
Debt/Equity ratio 0.91 0.91
Cost of debt 7.00% 96.50%
After-tax WACC 7.6% 50.5%
Selected WACC 29.0%